Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: New license

Nothing to do with hindsight, brother. It's a review of the decision-making capabilities of people who are supposed to be qualified to do so, but who have demonstrated, time and again, that they aren't up to par.

The ARS decision reveals incompetence, poor judgement and faulty vision. I don't need to sell and move on and/or run in horror. I need competent leadership, and deserve it, too, for my investment. Just my opinion.

Share
New Message
Please login to post a reply